Adjunctive Fluvoxamine for Schizophrenia: A Meta-analysis of Randomized Double-Blind, Placebo-Controlled Trials. Issue 4 (July 2020)
- Record Type:
- Journal Article
- Title:
- Adjunctive Fluvoxamine for Schizophrenia: A Meta-analysis of Randomized Double-Blind, Placebo-Controlled Trials. Issue 4 (July 2020)
- Main Title:
- Adjunctive Fluvoxamine for Schizophrenia
- Authors:
- Zheng, Wei
Xiang, Ying-Qiang
Cai, Dong-Bin
Yang, Xin-Hu
Zhang, Ling
Zheng, Wei
Lu, Xiao-Bing
Tong, Yan-Ming
Huang, Xiong
Ungvari, Gabor S.
Sim, Kang
Ning, Yu-Ping
Xiang, Yu-Tao - Abstract:
- Abstract: Background: This was a meta-analysis of double-blind, randomized controlled trials that examined the therapeutic effects and tolerability of adjunctive fluvoxamine versus placebo for schizophrenia. Methods: The Review Manager, Version 5.3, was used to analyze data. Results: Five double-blind randomized controlled trials (N = 284) covering 145 patients on adjunctive fluvoxamine and 139 patients on placebo were included in the analyses. Meta-analyses of total psychopathology, and negative, positive, and depressive symptoms did not show significant differences between the fluvoxamine and placebo groups. Two studies examined the effects of adjunctive fluvoxamine on cognitive functioning with mixed findings. Fluvoxamine was superior over placebo in lessening weight gain and metabolic abnormalities. Although fluvoxamine led to more discontinuation, no significant group differences were found regarding adverse drug reactions. Conclusions: There was inconsistent evidence for the therapeutic effect of adjunctive fluvoxamine on cognitive functions and preliminary evidence for alleviating metabolic syndrome caused by clozapine. More studies are needed to explore further the effectiveness of adjunctive fluvoxamine for schizophrenia. Abstract : Supplemental digital content is available in the text.
- Is Part Of:
- Journal of clinical psychopharmacology. Volume 40:Issue 4(2020)
- Journal:
- Journal of clinical psychopharmacology
- Issue:
- Volume 40:Issue 4(2020)
- Issue Display:
- Volume 40, Issue 4 (2020)
- Year:
- 2020
- Volume:
- 40
- Issue:
- 4
- Issue Sort Value:
- 2020-0040-0004-0000
- Page Start:
- Page End:
- Publication Date:
- 2020-07
- Subjects:
- fluvoxamine -- schizophrenia -- cognitive functions -- clozapine
Psychopharmacology -- Periodicals
Psychopharmacology -- Periodicals
Psychopharmacologie -- Périodiques
Psychopharmacology
Periodicals
615.78 - Journal URLs:
- http://journals.lww.com/psychopharmacology/pages/default.aspx ↗
http://www.psychopharmacology.com ↗
http://136.142.56.160/ovidweb/ovidweb.cgi?T=JS&MODE=ovid&NEWS=N&PAGE=toc&D=ovid_ovft&AN=00004714-000000000-00000 ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/JCP.0000000000001245 ↗
- Languages:
- English
- ISSNs:
- 0271-0749
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4958.691000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 13770.xml